On November 3rd and 4th, NIAID News and @CDCGov will host a virtual workshop on the epidemiology of #herpes simplex virus (HSV), in the US and worldwide. This event is open to the public: web.cvent.com/event/6be0297b…

Join NIMHD, NIH Office of Disease Prevention, NINR, NIAID News and others to hear about best practices for disseminating #RuralHealth research at the 2022 @NIH Rural Health Day Seminar! 11/17 @ 12 pm – 1:30 pm ET.

Learn more: bit.ly/3mt8wGx

Malaria News: One dose of a monoclonal antibody safely protected healthy, non-pregnant adults from #malaria infection during an intense six-month malaria season in Mali, Africa, an #NIAID -funded clinical trial found: bit.ly/3WfNq17
ASTMH #TropMed22

#HappyHalloween 🎃 Foods that don’t contain allergens can be made in the same place as foods that do. Read labels carefully and stay safe this Halloween! To learn more about food allergies, visit bit.ly/3U9GLDP #foodallergy

🚨 Registration for The Quest for Innovative Molecular Treatment Modalities for Intractable Disease Targets is open! 🚨 View the virtual workshop’s agenda & register before the event on Nov. 17 & 18: bit.ly/3e03Jhd

📷 Generated by the DALL-E neural network on OpenAI

An investigational monoclonal antibody provided nearly complete protection against Epstein-Barr virus infection and lymphoma in mice, according to a study led by #NIH and Walter Reed Bethesda scientists and published in the journal Immunity. bit.ly/3FpdoJy

#DYK that early introduction of peanut into an infant’s diet can prevent the development of peanut allergy? This National Nut Day, make sure you are up to date on the guidelines for prevention of peanut allergy in the U.S. Learn more: bit.ly/3RYJONm #foodallergy

Starting antiretroviral treatment early in the course of #HIV infection leads to better long-term health outcomes compared with delaying ART, according to a presentation at the #IDWeek conference. The findings are based on 5 years of follow-up data. bit.ly/3sdaEHp #IDSA

A three-dose course of HEPLISAV-B hepatitis B vaccine fully protected people with HIV who had never been vaccinated against or infected with the hepatitis B virus, according to findings presented today at the #IDWeek conference. bit.ly/3VJWUBo

Preventing new #HIV transmissions is a key step toward ending the HIV pandemic as we know it. Today, numerous prevention methods, such as PrEP, are available for use in combination or on their own. Read more about HIV prevention: bit.ly/3Ck3pmA #IIPW

Funding News niaid.nih.gov/grants-contrac…. Learn about when NIH uses cooperative agreements, how CSR reviews its study sections, what types of overlap NIH monitors, and more!

Honored to open a new UVRI NIH Virology lab in Entebbe, an example of ongoing 🇺🇸 support for building locally driven research capacity. This lab will 💪 🇺🇬’s capacity to understand endemic zoonotic diseases & develop countermeasures to prevent disease transmission in 🇺🇬 & 🌍.

Congrats to NIAID grantee Dr. Marc Rothenberg on being elected to the National Academy of Medicine! National Academy of Medicine recognized Dr. Rothenberg as a “thought leader in #allergy ” whose discoveries contributed to a new class of drugs: anti- #eosinophil therapy.

STDs are infections transmitted from an infected person to an uninfected person through sexual contact. Tools such as vaccines, topical microbicides, & behavioral interventions are a vital part of protecting against infectious diseases. Read more: bit.ly/3SGMzUy #IIPW

#DYK : We’re building a modernized ClinicalTrials.gov. 🔍💻See what’s new at beta.clinicaltrials.gov and share your thoughts with us. #ClinicalTrials Modernization #ClinicalTrials

National Latinx AIDS Awareness Day is October 15. HIV continues to disproportionately impact the Hispanic/Latino community, with Hispanic Americans accounting for almost 30% of all #HIV infection cases in 2019. Learn more about HIV/AIDS research: bit.ly/3BWBTtY #NLAAD